Qualigens Pharma Private Limited, a active private limited company, was established on 10 October 2013 in Khalapur, Maharashtra, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: U24100MH2013PTC249071. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.55 Cr.
It upholds a compliant status. Employing 226 professional, Its leadership includes Ajit Jain (Additional Director), Ankit Suresh Paharia (Director), Aayush Jain (Director). Past directors included Suresh Somchand Shah, Anu Yadav, Sumatiprakash Madanlal Jain. It holds ₹48.99 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Survey No. 151/2, At Village Umbre, Khopoli Pali Road,Taluka Khalapur,, Khalapur, Maharashtra, 410206.
U24100MH2013PTC249071
249071
10 October 2013
₹2.00 Cr
₹1.55 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Qualigens Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajit Jain | Additional Director | 10 Mar 2016 | Current |
| Ankit Suresh Paharia | Director | 10 Oct 2013 | Current |
| Aayush Jain | Director | 01 Aug 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Feb 2019 | Past |
| Pramod Abcsdd | Director | 21 Mar 2016 | Past |
| Pramod Abcsdd | Director | 28 Feb 2019 | Past |
| Pramod Abcsdd | Additional Director | 15 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Qualigens Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 45.61% increase. The company also saw a substantial improvement in profitability, with a 26.63% increase in profit. The company's net worth Soared by an impressive increase of 35.31%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Qualigens Pharma had a promoter holding of 0.65% and a public holding of 99.34%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹489,900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jul 2024 | Others | ₹5.00 Cr | Open |
| 22 Apr 2021 | Axis Bank Limited | ₹11.00 Cr | Open |
| 27 Feb 2020 | Others | ₹2.24 Cr | Open |
| 17 Jul 2019 | Others | ₹30.75 Cr | Open |
Explore comprehensive loan charge details -
Qualigens Pharma has a workforce of 226 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Qualigens Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qualigens Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Qualigens Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Qualigens Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
The activity A charge with Others of Rs. 5.00 Cr registered on 24 Jul 2024 with Charge ID 100963792 was modified on 21 Mar 2025. was completed.
A charge with Others of Rs. 30.75 Cr registered on 17 Jul 2019 with Charge ID 100275914 was modified on 21 Mar 2025. was recorded as a recent event.
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100963792 was registered on 24 Jul 2024. was recorded as a recent event.
A charge with Axis Bank Limited amounted to Rs. 11.00 Cr with Charge ID 100451504 was registered on 22 Apr 2021. was recorded as a recent event.
The CIN of Qualigens Pharma Private Limited is U24100MH2013PTC249071.
Qualigens Pharma Private Limited is headquartered at Survey No. 151/2, At Village Umbre, Khopoli Pali Road,Taluka Khalapur,, Khalapur, Maharashtra, 410206.
Qualigens Pharma Private Limited was incorporated on 10 October 2013.
The current directors of Qualigens Pharma Private Limited are
The primary industry of Qualigens Pharma Private Limited is Professional, Scientific And Technical.
Qualigens Pharma Private Limited is unlisted.
The authorized capital of Qualigens Pharma Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.55 Cr.
The compliance status of Qualigens Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX